APA (7th ed.) Citation

A, L., F, G., L, A., A, S., M, O., P, R., . . . A, C. (2026). First-in-human ex-vivo validation of carbonic anhydrase IX-PET for high-risk renal cancer (CAT-VHL - PNRR-POC-2023-12377493). Theranostics, 16(12), 6980. https://doi.org/10.7150/thno.122256

Chicago Style (17th ed.) Citation

A, Larcher, et al. "First-in-human Ex-vivo Validation of Carbonic Anhydrase IX-PET for High-risk Renal Cancer (CAT-VHL - PNRR-POC-2023-12377493)." Theranostics 16, no. 12 (2026): 6980. https://doi.org/10.7150/thno.122256.

MLA (9th ed.) Citation

A, Larcher, et al. "First-in-human Ex-vivo Validation of Carbonic Anhydrase IX-PET for High-risk Renal Cancer (CAT-VHL - PNRR-POC-2023-12377493)." Theranostics, vol. 16, no. 12, 2026, p. 6980, https://doi.org/10.7150/thno.122256.